Insider Buying: IDT Australia (ASX:IDT) Insider Acquires A$24,092.93 in Stock

IDT Australia Limited (ASX:IDT) insider Mark Simari bought 501,936 shares of the business’s stock in a transaction dated Wednesday, February 18th. The shares were bought at an average cost of A$0.05 per share, for a total transaction of A$24,092.93.

IDT Australia Price Performance

The stock has a market capitalization of $48.61 million, a PE ratio of -7.47 and a beta of 1.22. The company has a debt-to-equity ratio of 19.06, a current ratio of 1.34 and a quick ratio of 4.15.

IDT Australia Company Profile

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, chemistry and microbiology quality control laboratory, and quality assurance services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms.